Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis
Corresponding Author
Jens Otto Clemmesen
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Address reprint requests to: Otto Clemmesen, M.D., Department of Hepatology A-2121, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. fax: +45-35452913===Search for more papers by this authorAlexander L. Gerbes
Department of Medicine II, Klinikum Grosshadern, University of Münich, Germany
Search for more papers by this authorVeit Gülberg
Department of Medicine II, Klinikum Grosshadern, University of Münich, Germany
Search for more papers by this authorBent Adel Hansen
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorFin Stolze Larsen
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorClaus Skak
Department of Anesthesiology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorNiels Tygstrup
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorPeter Ott
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorCorresponding Author
Jens Otto Clemmesen
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Address reprint requests to: Otto Clemmesen, M.D., Department of Hepatology A-2121, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. fax: +45-35452913===Search for more papers by this authorAlexander L. Gerbes
Department of Medicine II, Klinikum Grosshadern, University of Münich, Germany
Search for more papers by this authorVeit Gülberg
Department of Medicine II, Klinikum Grosshadern, University of Münich, Germany
Search for more papers by this authorBent Adel Hansen
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorFin Stolze Larsen
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorClaus Skak
Department of Anesthesiology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorNiels Tygstrup
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorPeter Ott
Department of Hepatology, Rigshospitalet, University of Copenhagen, Denmark
Search for more papers by this authorAbstract
Liver failure represents a major therapeutic challenge, and yet basic pathophysiological questions about hepatic perfusion and oxygenation in this condition have been poorly investigated. In this study, hepatic blood flow (HBF) and splanchnic oxygen delivery (DO2,sp ) and oxygen consumption (VO2,sp) were assessed in patients with liver failure defined as hepatic encephalopathy grade II or more. Measurements were repeated after high-volume plasmapheresis (HVP) with exchange of 8 to 10 L of plasma. HBF was estimated by use of constant infusion of D-sorbitol and calculated according to Fick's principle from peripheral artery and hepatic vein concentrations. In 14 patients with acute liver failure (ALF), HBF (1.78 ± 0.78 L/min) and VO2,sp (3.9 ± 0.9 mmol/min) were higher than in 11 patients without liver disease (1.07 ± 0.19 L/min, P < .01) and (2.3 ± 0.7 mmol/min, P< .001). In 9 patients with acute on chronic liver disease (AOCLD), HBF (1.96 ± 1.19 L/min) and VO2,sp(3.9 ± 2.3 mmol/min) were higher than in 18 patients with stable cirrhosis (1.00 ± 0.36 L/min, P< .005; and 2.0 ± 0.6 mmol/min, P< .005). During HVP, HBF increased from 1.67 ± 0.72 to 2.07 ± 1.11 L/min (n=11) in ALF, and from 1.89 ± 1.32 to 2.34 ± 1.54 L/min (n=7) in AOCLD,P < .05 in both cases. In patients with ALF, cardiac output (thermodilution) was unchanged (6.7 ± 2.5 vs. 6.6 ± 2.2 L/min, NS) during HVP. Blood flow was redirected to the liver as the systemic vascular resistance index increased (1,587 ± 650 vs. 2,020 ± 806 Dyne · s · cm−5 · m2, P< .01) whereas splanchnic vascular resistance was unchanged. In AOCLD, neither systemic nor splanchnic vascular resistance was affected by HVP, but as cardiac output increased from 9.1 ± 2.8 to 10.1 ± 2.9 L/min (P< .01) more blood was directed to the splanchnic region. In all liver failure patients treated with HVP (n=18), DO2,spincreased by 15% (P< .05) whereas VO2,sp was unchanged. Endothelin-1 (ET-1) and ET-3 were determined before and after HVP. Changes of ET-1 were positively correlated with changes in HBF (P< .005) and VO2,sp (P< .05), indicating a role for ET-1 in splanchnic circulation and oxygenation. ET-3 was negatively correlated with systemic vascular resistance index before HVP (P< .05) but changes during HVP did not correlate. Our data suggest that liver failure is associated with increased HBF and VO2,sp. HVP further increased HBF and DO2,sp but VO2,spwas unchanged, indicating that splanchnic hypoxia was not present.
References
- 1 Skak C, Keiding S. Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver 1987; 7: 155–162.MEDLINE
- 2 Clemmesen JO, Tygstrup N, Ott P. Hepatic plasma flow estimated according to Fick's principle in patients with hepatic encephalopathy. Evaluation of indocyanine green and D-sorbitol as test substances. Hepatology 1998; 27: 666–673.MEDLINE
- 3 Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852–1857.MEDLINE
- 4 Wendon JA, Harrison PM, Keays R, Gimson AES, Alexander GJM, Williams R. Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure. Hepatology 1992; 15: 1067–1071.MEDLINE
- 5 Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R. N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 1997; 25: 236–245.MEDLINE
- 6 Makin AJ, Hughes RD, Williams R. Systemic and hepatic hemodynamic changes in acute liver injury. Am J Physiol 1997; 272: G617–G625.MEDLINE
- 7 Kondrup J, Almdal T, Vilstrup H, Tygstrup N. High volume plasma exchange in fulminant hepatic failure. Int J Artif Orgs 1992; 11: 669–676.
- 8 Tygstrup N, Larsen FS, Hansen BA. Treatment of acute liver failure by high volume plasmapheresis. In: WM Lee, R Williams, eds. Acute Liver failure. Cambridge: Cambridge University Press. 1997; 267–277.
- 9 Clemmesen JO, Larsen FS, Hansen BA, Ejlersen E, Schiødt FV, Ott P, Hansen BA. Hemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure. Eur J Gastroenterol Hepatol 1997; 9: 55–60.MEDLINE
- 10 Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH. Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: Relationship with oxygen consumption. Eur J Gastroenterol Hepatol 1995; 7: 887–892.MEDLINE
- 11 Gerbes AL, Møller S, Gülberg V, Henriksen JH. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: Role of splanchnic and renal passage and liver function. Hepatology 1995; 21: 735–739.MEDLINE
- 12 Møller S, Gülberg V, Henriksen JH, Gerbes AL. Endothelin-1 and -3 in cirrhosis: Relations to systemic and splanchnic hemodynamics. J Hepatol 1995; 23: 135–144.MEDLINE
- 13 Shah V, Garcia-Cardena G, Sessa WC, Groszmann RJ. The hepatic circulation in health and disease: Report of a single-topic symposium. Hepatology 1998; 27: 279–288.MEDLINE
- 14 Ott P, Keiding S, Bass L. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: Comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis. Hepatology 1993; 18: 1504–1515.MEDLINE
- 15 Gülberg V, Gerbes AL, Vollmar AM, Paumgartner G. Endothelin-3 like immunoreactivity in plasma of patients with cirrhosis of the liver. Life Sci 1992; 51: 1165–1169.MEDLINE
- 16 Keiding S, Johansen S, Midtbøll I, Rabøl A, Christiansen L. Ethanol elimination kinetics in human liver and pig liver in vivo. Am J Physiol 1979; 237: E316–E324.MEDLINE
- 17 Little RA, Edwards JD. Applied physiology. SD Edwards, WC Shoemaker, JL Vincent, eds: Oxygen Transport. Principles and Practice. London: Saunders. E316–E324.
- 18 Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297–301.MEDLINE
- 19 Leithe ME, Hermiller JB, Magorien RD, Unverferth DV, Leier CV. The effect of age on central and regional hemodynamics. Gerontology 1984; 30: 240–246.MEDLINE
- 20 Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, et al. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 1988; 95: 749–759.MEDLINE
- 21 Molino G, Avagnina P, Ballaré M, Torchio M, Niro AG, Aurucci PE, Grosso M, et al. Combined evaluation of total and functional liver plasma flows and intrahepatic shunting. Dig Dis Sci 1991; 36: 1189–1196.MEDLINE
- 22 Keiding S, Engsted E, Ott P. Sorbitol as a test substance for measurement of liver plasma flow in humans. Hepatology 1998; 28: 50–56.MEDLINE
- 23 Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin. Gastroenterology 1981; 80: 518–525.MEDLINE
- 24 Barbare JC, Poupon R, Jaillon P, Bories P, Aussanaire M, Darnis F, Michel H, et al. The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: A study of the effects of posterior pituitary extract, vasopressin, and somastostatin. Hepatology 1984; 4: 59–62.MEDLINE
- 25 Jones AL, Bangash IH, Bouchier IAD, Hayes PC. Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. Gut 1994; 35: 1290–1293.MEDLINE
- 26 Luca A, Feu F, Garcia-Pagan JC, Jimenez W, Arroyo V, Bosch J, Rodes J. Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascitis. Hepatology 1994; 20: 30–33.MEDLINE
- 27 Gaudin C, Braillon A, Poo JL, Moreau R, Hadengue A, Lebrec D. Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis. J Hepatol 1991; 13: 161–168.MEDLINE
- 28 Braillon A, Gaudin C, Poo JL, Moreau R, Debaene B, Lebrec D. Plasma catecolamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis. J Hepatol 1992; 15: 58–62.
- 29 MacMathuna P, Vlavianos P, Wendon J, Gove CD, Westaby D, Williams R. Metabolic effects of beta-adrenergic receptor blockade in advanced alcoholic cirrhosis. J Hepatol 1993; 17: 74–80.MEDLINE
- 30 Bacq Y, Gaudin C, Hadengue A, Roulot D, Braillon A, Moreau R, Lebrec D. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology 1991; 14: 483–487.MEDLINE
- 31 Hadengue A, Moreau R, Bacq Y, Gaudin C, Braillon A, Lebrec D. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study. Hepatology 1991; 13: 111–116.MEDLINE
- 32 Hadengue A, Lebrec D, Moreau R, Sogni P, Durand F, Gaudin C, Bernuau J, et al. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 1993; 17: 175–178.MEDLINE
- 33 Navasa M, Feu F, Garcia-Pagan JC, Jimenez W, Llach J, Rimola A, Bosch J, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology 1993; 17: 355–360.MEDLINE
- 34 Villeneuve JP, Huot R, Marleau D, Huet PM. The estimation of hepatic blood flow with indocyanine green: Comparison between the continuous infusion and single injection methods. Am J Gastroenterol 1982; 77: 233–237.MEDLINE
- 35 Garcia-Pagan JC, Feu F, Luca A, Fernandez M, Pizcueta P, Bosch J, Rodes J. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis. J Hepatol 1994; 20: 792–796.MEDLINE
- 36 Kakumitsu S, Shijo H, Yokoyama M, Kim T, Akiyoshi N, Ota K, Kubara K, et al. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis. Hepatology 1998; 27: 377–382.MEDLINE
- 37 Bircher J, Blankart R, Halpern A, Häcki W, Laissue J, Preisig R. Criteria for assesment of functional impairment in patients with cirrhosis of the liver. Eur J Clin Invest 1973; 3: 72–85.MEDLINE
- 38 Møller S, Becker U, Schifter S, Abrahamsen J, Henriksen JH. Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 1996; 25: 316–328.MEDLINE
- 39 Groszmann R, Kotelanski B, Cohn JN, Khatri IM. Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease. Am J Med 1972; 53: 715–722.MEDLINE
- 40 Reemtsma K, Hottinger GC, Degraff AC, Creech O. The estimation of hepatic blood flow using indocyanine green. Surg Gynecol Obs 1960; 110: 353–356.
- 41 Leevy CM, Mendenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. J Clin Invest 1962; 41: 1169–1179.
- 42 Wiegand BD, Ketterer SG, Rapaport E. The use of indocyanine green for the evaluation of hepatic function and blood flow in man. Am J Dig Dis 1960; 5: 427–436.
- 43 Jacobsen KR, Ranek L, Tygstrup N. Liver function and blood flow in normal man during infusion of vasopressin. Scand J Clin Lab Invest 1969; 24: 279–284.MEDLINE
- 44 Simonsen L, Ryge C, Bulow J. Glucose-induced thermogenesis in splanchnic and leg tissues in man. Clin Sci Colch 1995; 88: 543–550.MEDLINE
- 45 Rowell LB. Control of regional blood flow during dynamic excercise. Human Cardiovascular Control. Oxford, Oxford University Press 1993; 204–254.
- 46 Bendtsen F, Henriksen JH, Becker U, Sørensen TI. Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosis. J Hepatol 1987; 5: 137–143.MEDLINE
- 47 Walsh TS, Hopton P, Philips BJ, Mackenzie SJ, Lee A. The effect of N-Acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure. Hepatology 1998; 27: 1332–1340.MEDLINE
- 48 Forrest EH, Jones AL, Dillon JF, Walker J, Hayes PC. The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. J Hepatol 1995; 23: 254–258.MEDLINE
- 49 Henderson JM, Mackay GJ, Hooks M, Chezmar JL, Galloway JR, Dodson TF, Kutner MH. High cardiac output of advanced liver disease persists after orthotopic liver transplantation. Hepatology 1992; 15: 258–262.MEDLINE
- 50 Schneider F, Lutun P, Boudjema K, Wolf P, Tempé JD. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology 1994; 19: 38–44.MEDLINE
- 51 Unneberg K, Mjaaland M, Helseth E, Revhaug A. Effects of endothelin-1 on hepatic blood flow. H P B Surg 1996; 9: 153–9.
- 52 Zhu ZG, Li HH, Zhang BR. Expression of endothelin-1 and constitutional nitric oxide synthase messenger RNA in saphenous vein endothelial cells exposed to arterial flow shear stress. Ann Thorac Surg 1997; 64: 1333–1338.MEDLINE
- 53 Zhang JX, Pegoli WJ, Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids Am J Physiol 1994; 266: G624–G632.MEDLINE
- 54 Housset C, Rockey DC, Bissell DM. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci 1993; 90: 9266–9270.MEDLINE
- 55 Kawada N, Thran-Thi TA, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin-1 and nitric oxide in the regulation of the sinisoidal tonus. Eur J Biochem 1993; 213: 815–823.MEDLINE
- 56 Berthiaume N, Claing A, Yano M, D'Orleans-Juste P. Characterization of receptors for endothelins in the guinea pig mesenteric vasculature. J Cardiovasc Pharmacol 1995; 26(Suppl 3): S317–S319.MEDLINE
- 57 D'Orleans-Juste P, Claing A, Warner TD, Yano M, Telemaque S. Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br J Pharmacol 1993; 110: 687–692.MEDLINE
- 58 O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439–445.MEDLINE